ACIP Prevenar Coverage Recommendation Includes Prioritization Plan
Executive Summary
The Advisory Committee on Immunization Practices' coverage recommendation for Wyeth-Lederle's pending 7-valent pneumococcal conjugate vaccine Prevenar includes a prioritization plan to direct use of the product in the face of fiscal or supply limitations.
You may also be interested in...
Wyeth To Seek Prevenar Otitis Media Indication In Future Submission
Wyeth-Lederle plans to seek an indication for its pneumococcal conjugate vaccine Prevenar for the prevention of otitis media in a future submission to FDA.
Wyeth To Seek Prevenar Otitis Media Indication In Future Submission
Wyeth-Lederle plans to seek an indication for its pneumococcal conjugate vaccine Prevenar for the prevention of otitis media in a future submission to FDA.
Wyeth Withdraws RotaShield Ahead Of Rotavirus Season And ACIP Review
Wyeth-Lederle Vaccines is withdrawing the RotaShield rotavirus vaccine because recently gathered epidemiological data continue to suggest links to intussusception.